{"DataElement":{"publicId":"3733517","version":"1","preferredName":"Synovial Sarcoma SS18-SSX Fusion Protein Expression Testing Method Type","preferredDefinition":"Text term that represents the laboratory test method used to obtain the result of the laboratory test for the SS18-SSX fusion protein expression status for the synovial sarcoma.","longName":"3733278v1.0:3733331v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3733278","version":"1","preferredName":"Synovial Sarcoma SS18-SSX Fusion Protein Expression Testing Method","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.:The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"3733271v1.00:3733276v1.00","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3733271","version":"1","preferredName":"Synovial Sarcoma","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","longName":"C3400","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB80D3A8-F8BF-C419-E040-BB89AD435340","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3733276","version":"1","preferredName":"SS18-SSX Fusion Protein Expression Laboratory Procedure Method","preferredDefinition":"No Value Exists:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C43306:C25294:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SS18-SSX Fusion Protein Expression","conceptCode":"C43306","definition":"The expression of fusion proteins that result from a chromosomal aberration, t(X;18)(p11.2;q11.2), which fuses the first 10 exons of the SS18 gene with exon six of one of three SSX genes (SSX1, SSX2 or SSX4) and is associated with synovial sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB80D3A8-F8FE-C419-E040-BB89AD435340","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB80D3A8-F90F-C419-E040-BB89AD435340","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"KUMMEROA","dateModified":"2023-07-25","changeDescription":"Created for TCGA Sarcoma form per request by T.Lichtenberg. mc 4/29/13","administrativeNotes":"2023.7.25 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3733331","version":"1","preferredName":"SS18-SSX Fusion Protein Test Method Type","preferredDefinition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal. _Something distinguishable as an identifiable class based on common qualities.","longName":"3733331v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB80D3A8-FB13-C419-E040-BB89AD435340","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","deletedIndicator":"No"},{"value":"Both","valueDescription":"Both","ValueMeaning":{"publicId":"3689450","version":"1","preferredName":"Both","longName":"3689450","preferredDefinition":"One and the other; relating to or being two in conjunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6333A5E-0775-2814-E040-BB89AD43013F","latestVersionIndicator":"Yes","beginDate":"2013-02-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB80D3A8-FB1D-C419-E040-BB89AD435340","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","deletedIndicator":"No"},{"value":"FISH for SS18 split","valueDescription":"TLE1 Gene Fluorescence in situ Hybridization","ValueMeaning":{"publicId":"3733332","version":"1","preferredName":"TLE1 Gene Fluorescence in situ Hybridization","longName":"3733332","preferredDefinition":"This gene is involved in the modulation of gene transcription.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"TLE1 Gene","conceptCode":"C104860","definition":"This gene is involved in the modulation of gene transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB80D3A8-FB2B-C419-E040-BB89AD435340","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB80D3A8-FB44-C419-E040-BB89AD435340","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","deletedIndicator":"No"},{"value":"RT-PCR","valueDescription":"RT-PCR","ValueMeaning":{"publicId":"3121570","version":"1","preferredName":"RT-PCR","longName":"3121570","preferredDefinition":"RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E9B3-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB80D3A8-FB4E-C419-E040-BB89AD435340","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"ONEDATA","dateModified":"2013-04-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB80D3A8-FAFD-C419-E040-BB89AD435340","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"COOPERM","dateModified":"2013-07-19","changeDescription":"Created for TCGA Sarcoma Form per request by T.Lichtenberg. mc 4/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Synovial Sarcoma: SS18-SSX Te","type":"Preferred Question Text","description":"Synovial Sarcoma: SS18-SSX Testing Method","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB84F5E4-3FF8-BAE8-E040-BB89AD43275B","latestVersionIndicator":"Yes","beginDate":"2013-04-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-04-29","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for TCGA Sarcoma form per request by T.Lichtenberg. mc 4/29/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}